`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AGILA SPECIALTIES INC. AND
`
`MYLAN PHARMACEUTICALS INC,
`‘
`Petitioners,
`
`CUBIST PHARMACEUTICALS, INC.,
`Patent Owner
`'
`
`Patent No. 8,058,238
`
`Case 1PR2015 UNASSIGNED
`
`MOTION TO REQUEST ACCEPTANCE OF MAILED PETITION FOR
`
`INTER PARTES REVIEW OF U.S. PATENT N0. 8,058,238
`UNDER 37 C.F.R. §42.6(b)(2)(i)(A)
`
`CUBIST 2002
`CUBIST 2002
`AGILA v. CUBIST
`IPR2015-00144
`
`AGILA v. CUBIST
`
`IPR2015-00144
`
`-1-
`
`-1-
`
`
`
`Petitioners submitthis motion under 37 CPR. §42.6(2)(i)(A)'to file the
`
`—\
`
`attached Petition for Inter Partes Review of U.S. Patent No. 8,05 8,238 challenging
`
`claims 10-36, 43-47 and 176-192 under 37 CWFR 42.6(2)(i)(A) and request
`
`acceptance of this submission and a filing date of October 23, 2014. Petitioners .
`
`attempted to file this Petition by Electronic Filing, but encountered difficulties with
`
`the Patent Review Processing System website. Petitioners accordingly have filed this
`
`Petition via Priority Express Mail Under 37 CPR. 1.10, and hereby certify that this -
`
`Petition is being Express-Mailedon October 23, 2014.
`
`Respectfully submitted,
`
`
`Dated: October 23 2014
`
`/Peter R. Munson/
`
`Peter R. Munson
`Reg. No. 43,821
`Lead Attorney for Petitioners
`
`C:\Users\PBStafi\AppData\Local\Microsofi\Windows\Temporary Internet Files\Content.IES\Y81Q5EHK\Document9 [Compatibility Mode].doex
`
`-
`
`-2-
`
`